# PYRIDOSTIGMINE BROMIDE
> **NDA217604** · New Drug Application · Sponsor: AMNEAL · Approved 2024-10-04
## Drug
- **FDA Application Number:** NDA217604
- **Application type:** New Drug Application
- **Brand name:** PYRIDOSTIGMINE BROMIDE
- **Generic name:** PYRIDOSTIGMINE BROMIDE
- **Active ingredients:** PYRIDOSTIGMINE BROMIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** AMNEAL
- **Manufacturer:** Amneal Pharmaceuticals LLC
- **First approval:** 2024-10-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217604)
---
*AI Analytics · CC0 1.0*